Antegrin Therapeutics
St. Louis, US · Founded 2014
Biotech
Founders & leadership
CB
Charles BoltenDirector
GH
George H. Capps, IIExecutive Officer
RW
Robert W. KarrExecutive Officer, Director
MA
Michael A. YeadonDirector
DW
David W. GriggsDirector
TP
Thomas P. CirritoDirector
RP
Rajesh P. DevrajDirector
Reported raises · per SEC filings
Form D private placements$9MraisedAug 2017 · 6 investors · Pharmaceuticals
Rule 506(c)$100KraisedOct 2015 · 1 investors · Pharmaceuticals
Rule 506(c)$595.6KraisedOct 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.